DNA N6-Adenine methylation in HBV-related hepatocellular carcinoma

Gene. 2022 May 15:822:146353. doi: 10.1016/j.gene.2022.146353. Epub 2022 Feb 18.

Abstract

DNA methylation on N6-adenine (6mA) has recently been found to be a potential epigenetic marker in prokaryotes and eukaryotes. However, its distribution patterns and potential functions in human tumorigenesis remain largely unknown. Here, we reported global profiling of 6mA sites in the genome of hepatocellular carcinoma at single-nucleotide resolution using Nanopore sequencing. 6mA was widely distributed throughout the human genome. The 6mA sites were related to the porphyrin and chlorophyll metabolism in autosomes and were related to oxidative phosphorylation and ATP metabolism in mitochondria. AGG was the most significant motif associated with 6mA modification and the prevalent motifs in tumors were mainly distributed in mitochondria. The density of 6mA was related to the activation of gene transcription and 6mA density in repetitive sequences decreased in hepatocellular carcinoma. DNA 6mA methylation modification may also be a potential biomarker for cancer diagnosis and treatment.

Keywords: 6mA; Hepatocellular carcinoma; Nanopore sequencing.

MeSH terms

  • Adenine / chemistry*
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / virology*
  • DNA Methylation
  • Epigenesis, Genetic
  • Genome-Wide Association Study
  • Hepatitis B / genetics*
  • Hepatitis B virus / pathogenicity
  • Humans
  • Introns
  • Liver Neoplasms / genetics
  • Liver Neoplasms / virology*
  • Mitochondria / genetics*
  • Nanopore Sequencing
  • Repetitive Sequences, Nucleic Acid

Substances

  • Adenine